比亞迪股份(1211.HK)一度漲超8% 為巴菲特第八大重倉股
格隆匯3月1日丨此前持續回調多日的比亞迪股份(1211.HK)今日盤中拉昇,一度漲超8%報213.8港元;A股半日收漲3.87%報204.91元。27日公佈的巴菲特股東信顯示,比亞迪是巴菲特的第八大重倉股。截至去年底,伯克希爾持有2.25億股比亞迪,市值為58.97億美元。2008年9月,巴菲特以每股8港元的價格認購2.25億股比亞迪公司H股,交易價格總金額約為18億港元(約2.3億美元)。此後,巴菲特從未賣出過比亞迪。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.